Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein(a) ...
Amgen is a leading biopharmaceutical company that develops innovative medicines in areas with significant unmet needs. Read ...
AbbVie is grappling with diminishing Humira sales and is also trading at an above-average P/E. See why I rate ABBV stock as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback